| UniProt ID | DNJA2_HUMAN | |
|---|---|---|
| UniProt AC | O60884 | |
| Protein Name | DnaJ homolog subfamily A member 2 | |
| Gene Name | DNAJA2 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 412 | |
| Subcellular Localization |
Membrane Lipid-anchor . |
|
| Protein Description | Co-chaperone of Hsc70. Stimulates ATP hydrolysis and the folding of unfolded proteins mediated by HSPA1A/B (in vitro). [PubMed: 24318877] | |
| Protein Sequence | MANVADTKLYDILGVPPGASENELKKAYRKLAKEYHPDKNPNAGDKFKEISFAYEVLSNPEKRELYDRYGEQGLREGSGGGGGMDDIFSHIFGGGLFGFMGNQSRSRNGRRRGEDMMHPLKVSLEDLYNGKTTKLQLSKNVLCSACSGQGGKSGAVQKCSACRGRGVRIMIRQLAPGMVQQMQSVCSDCNGEGEVINEKDRCKKCEGKKVIKEVKILEVHVDKGMKHGQRITFTGEADQAPGVEPGDIVLLLQEKEHEVFQRDGNDLHMTYKIGLVEALCGFQFTFKHLDGRQIVVKYPPGKVIEPGCVRVVRGEGMPQYRNPFEKGDLYIKFDVQFPENNWINPDKLSELEDLLPSRPEVPNIIGETEEVELQEFDSTRGSGGGQRREAYNDSSDEESSSHHGPGVQCAHQ | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 10 | Phosphorylation | NVADTKLYDILGVPP CCCCCCHHHHHCCCC | 11.51 | 27642862 | |
| 20 | Phosphorylation | LGVPPGASENELKKA HCCCCCCCHHHHHHH | 47.04 | 25693802 | |
| 25 | Ubiquitination | GASENELKKAYRKLA CCCHHHHHHHHHHHH | 29.22 | 21906983 | |
| 25 | Acetylation | GASENELKKAYRKLA CCCHHHHHHHHHHHH | 29.22 | 25953088 | |
| 26 | Ubiquitination | ASENELKKAYRKLAK CCHHHHHHHHHHHHH | 64.37 | 21906983 | |
| 33 | Ubiquitination | KAYRKLAKEYHPDKN HHHHHHHHHHCCCCC | 70.06 | - | |
| 33 | Acetylation | KAYRKLAKEYHPDKN HHHHHHHHHHCCCCC | 70.06 | 7683259 | |
| 35 | Phosphorylation | YRKLAKEYHPDKNPN HHHHHHHHCCCCCCC | 20.25 | 28152594 | |
| 39 | Acetylation | AKEYHPDKNPNAGDK HHHHCCCCCCCCCHH | 77.93 | - | |
| 39 | Ubiquitination | AKEYHPDKNPNAGDK HHHHCCCCCCCCCHH | 77.93 | 21906983 | |
| 46 | 2-Hydroxyisobutyrylation | KNPNAGDKFKEISFA CCCCCCHHHHHCHHH | 58.37 | - | |
| 46 | Ubiquitination | KNPNAGDKFKEISFA CCCCCCHHHHHCHHH | 58.37 | 21890473 | |
| 46 | Acetylation | KNPNAGDKFKEISFA CCCCCCHHHHHCHHH | 58.37 | 25953088 | |
| 51 | Phosphorylation | GDKFKEISFAYEVLS CHHHHHCHHHHHHHC | 12.62 | 28152594 | |
| 54 | Phosphorylation | FKEISFAYEVLSNPE HHHCHHHHHHHCCHH | 12.45 | 25839225 | |
| 54 | Nitration | FKEISFAYEVLSNPE HHHCHHHHHHHCCHH | 12.45 | - | |
| 58 | Phosphorylation | SFAYEVLSNPEKREL HHHHHHHCCHHHHHH | 56.36 | 28152594 | |
| 62 | Ubiquitination | EVLSNPEKRELYDRY HHHCCHHHHHHHHHH | 53.05 | 21906983 | |
| 66 | Phosphorylation | NPEKRELYDRYGEQG CHHHHHHHHHHHHHC | 8.14 | 28152594 | |
| 68 | Methylation | EKRELYDRYGEQGLR HHHHHHHHHHHHCCC | 28.00 | - | |
| 69 | Phosphorylation | KRELYDRYGEQGLRE HHHHHHHHHHHCCCC | 23.32 | 25839225 | |
| 78 | Phosphorylation | EQGLREGSGGGGGMD HHCCCCCCCCCCCHH | 29.52 | 22617229 | |
| 121 | Acetylation | EDMMHPLKVSLEDLY CCCCCCEECCHHHHH | 33.94 | 25953088 | |
| 123 | Phosphorylation | MMHPLKVSLEDLYNG CCCCEECCHHHHHCC | 25.18 | 25849741 | |
| 128 | Phosphorylation | KVSLEDLYNGKTTKL ECCHHHHHCCCCCEE | 33.90 | 29449344 | |
| 131 | Ubiquitination | LEDLYNGKTTKLQLS HHHHHCCCCCEEEEC | 49.75 | 21906983 | |
| 131 | Acetylation | LEDLYNGKTTKLQLS HHHHHCCCCCEEEEC | 49.75 | 30588259 | |
| 134 | Ubiquitination | LYNGKTTKLQLSKNV HHCCCCCEEEECCCE | 39.19 | 21906983 | |
| 134 | Acetylation | LYNGKTTKLQLSKNV HHCCCCCEEEECCCE | 39.19 | 23749302 | |
| 134 | Sumoylation | LYNGKTTKLQLSKNV HHCCCCCEEEECCCE | 39.19 | 28112733 | |
| 134 | 2-Hydroxyisobutyrylation | LYNGKTTKLQLSKNV HHCCCCCEEEECCCE | 39.19 | - | |
| 139 | Ubiquitination | TTKLQLSKNVLCSAC CCEEEECCCEEEHHH | 60.72 | - | |
| 144 | Phosphorylation | LSKNVLCSACSGQGG ECCCEEEHHHCCCCC | 28.31 | 25159151 | |
| 147 | Phosphorylation | NVLCSACSGQGGKSG CEEEHHHCCCCCCCC | 33.59 | 25159151 | |
| 152 | Acetylation | ACSGQGGKSGAVQKC HHCCCCCCCCHHEEC | 53.17 | 26051181 | |
| 152 | Ubiquitination | ACSGQGGKSGAVQKC HHCCCCCCCCHHEEC | 53.17 | 21906983 | |
| 153 | Phosphorylation | CSGQGGKSGAVQKCS HCCCCCCCCHHEECH | 34.95 | - | |
| 158 | Acetylation | GKSGAVQKCSACRGR CCCCHHEECHHCCCC | 24.45 | 25953088 | |
| 158 | Ubiquitination | GKSGAVQKCSACRGR CCCCHHEECHHCCCC | 24.45 | 21906983 | |
| 158 | 2-Hydroxyisobutyrylation | GKSGAVQKCSACRGR CCCCHHEECHHCCCC | 24.45 | - | |
| 184 | Phosphorylation | GMVQQMQSVCSDCNG HHHHHHHHHHHHCCC | 21.54 | 28348404 | |
| 187 | Phosphorylation | QQMQSVCSDCNGEGE HHHHHHHHHCCCCCC | 42.94 | 24719451 | |
| 199 | Acetylation | EGEVINEKDRCKKCE CCCCCCCCHHCCCCC | 46.08 | 26051181 | |
| 199 | Ubiquitination | EGEVINEKDRCKKCE CCCCCCCCHHCCCCC | 46.08 | 21906983 | |
| 223 | Acetylation | ILEVHVDKGMKHGQR EEEEEECCCCCCCCE | 60.87 | 25953088 | |
| 255 | Ubiquitination | IVLLLQEKEHEVFQR EEEEEECCCCHHHCC | 51.95 | - | |
| 297 | Ubiquitination | DGRQIVVKYPPGKVI CCCEEEEECCCCCEE | 40.94 | - | |
| 302 | Methylation | VVKYPPGKVIEPGCV EEECCCCCEECCCCE | 45.90 | - | |
| 302 | Ubiquitination | VVKYPPGKVIEPGCV EEECCCCCEECCCCE | 45.90 | - | |
| 302 | "N6,N6-dimethyllysine" | VVKYPPGKVIEPGCV EEECCCCCEECCCCE | 45.90 | - | |
| 317 | Sulfoxidation | RVVRGEGMPQYRNPF EEECCCCCCCCCCCC | 1.30 | 30846556 | |
| 326 | Acetylation | QYRNPFEKGDLYIKF CCCCCCCCCCEEEEE | 59.09 | 26051181 | |
| 326 | Ubiquitination | QYRNPFEKGDLYIKF CCCCCCCCCCEEEEE | 59.09 | 21906983 | |
| 330 | Phosphorylation | PFEKGDLYIKFDVQF CCCCCCEEEEEEEEC | 13.55 | - | |
| 349 | Phosphorylation | WINPDKLSELEDLLP EECHHHHHHHHHHCC | 45.97 | 20068231 | |
| 357 | Phosphorylation | ELEDLLPSRPEVPNI HHHHHCCCCCCCCCC | 61.51 | 29632367 | |
| 368 | Phosphorylation | VPNIIGETEEVELQE CCCCCCCCCEEEEEE | 32.03 | 20068231 | |
| 378 | Phosphorylation | VELQEFDSTRGSGGG EEEEECCCCCCCCCC | 25.89 | 29632367 | |
| 379 | Phosphorylation | ELQEFDSTRGSGGGQ EEEECCCCCCCCCCC | 40.68 | 29632367 | |
| 382 | Phosphorylation | EFDSTRGSGGGQRRE ECCCCCCCCCCCCCC | 30.86 | 29632367 | |
| 391 | Phosphorylation | GGQRREAYNDSSDEE CCCCCCCCCCCCCCC | 18.10 | 26846344 | |
| 394 | Phosphorylation | RREAYNDSSDEESSS CCCCCCCCCCCCHHC | 35.73 | 26503892 | |
| 395 | Phosphorylation | REAYNDSSDEESSSH CCCCCCCCCCCHHCC | 52.48 | 26503892 | |
| 399 | Phosphorylation | NDSSDEESSSHHGPG CCCCCCCHHCCCCCC | 34.78 | 23663014 | |
| 400 | Phosphorylation | DSSDEESSSHHGPGV CCCCCCHHCCCCCCC | 36.65 | 23663014 | |
| 401 | Phosphorylation | SSDEESSSHHGPGVQ CCCCCHHCCCCCCCC | 28.87 | 28450419 | |
| 409 | Farnesylation | HHGPGVQCAHQ---- CCCCCCCCCCC---- | 3.20 | 15308774 | |
| 409 | Farnesylation | HHGPGVQCAHQ---- CCCCCCCCCCC---- | 3.20 | 15308774 | |
| 409 | Methylation | HHGPGVQCAHQ---- CCCCCCCCCCC---- | 3.20 | - |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of DNJA2_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of DNJA2_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of DNJA2_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| HIRA_HUMAN | HIRA | physical | 17242198 | |
| RB_HUMAN | RB1 | physical | 17242198 | |
| ERG_HUMAN | ERG | physical | 19940115 | |
| ABCF2_HUMAN | ABCF2 | physical | 26344197 | |
| PYR1_HUMAN | CAD | physical | 26344197 | |
| TCPD_HUMAN | CCT4 | physical | 26344197 | |
| DCTN1_HUMAN | DCTN1 | physical | 26344197 | |
| HSP7C_HUMAN | HSPA8 | physical | 26344197 | |
| GRP75_HUMAN | HSPA9 | physical | 26344197 | |
| PSA6_HUMAN | PSMA6 | physical | 26344197 | |
| SMC3_HUMAN | SMC3 | physical | 26344197 | |
| TCPA_HUMAN | TCP1 | physical | 26344197 | |
| TBB4B_HUMAN | TUBB4B | physical | 26344197 | |
| XPO1_HUMAN | XPO1 | physical | 26344197 | |
| DNJB1_HUMAN | DNAJB1 | physical | 28504929 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-78, AND MASSSPECTROMETRY. | |
| "Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-78, AND MASSSPECTROMETRY. | |
| Prenylation | |
| Reference | PubMed |
| "A tagging-via-substrate technology for detection and proteomics offarnesylated proteins."; Kho Y., Kim S.C., Jiang C., Barma D., Kwon S.W., Cheng J.,Jaunbergs J., Weinbaum C., Tamanoi F., Falck J., Zhao Y.; Proc. Natl. Acad. Sci. U.S.A. 101:12479-12484(2004). Cited for: ISOPRENYLATION AT CYS-409. | |